Advancing Innovations in Vaginal Microbiome Science
Vaginal Biome Science is an innovative R&D company with deep expertise in transforming microbiome science into clinically validated consumer healthcare solutions.
Our groundbreaking work includes patented BioMatch® technology, clinically proven to optimize vaginal pH and support beneficial Lactobacillus, the VENUS Study, one of the largest observational vaginal microbiome studies in the United States, and innovations in diagnostics to advance precision care. We are pioneering personalized solutions that transform vaginal health, improve clinical outcomes, and empower women with actionable insights.
Vaginal Biome Science (VBS) is an innovative R&D and biotechnology company with deep expertise in transforming microbiome science into clinically validated consumer healthcare solutions. We are dedicated to improving women’s vaginal health through cutting-edge measurement of the microbiome and patented product formulations. We believe in a future where vaginal health is measurable, manageable, and respected as a core component of women’s health.
The vaginal microbiome is central to a woman’s physical, emotional, sexual, and reproductive health. Yet the existing standard of women’s healthcare lacks the tools, knowledge, and infrastructure to address these needs in a personalized, effective way. Our new qPCR technology was built to address why two out of three vaginal infections are misdiagnosed. Standard of care treatments lead with one-size-fits-all approaches like antibiotics and steroids that fail to address the root causes of vaginal dysbiosis. And the vast majority of affected women either never seek care or give up after years of unsuccessful treatment. Our work initiatives are designed to close this gap.
Our new qPCR technology was built to address why two out of three vaginal infections are misdiagnosed. Standard of care treatments lead with one-size-fits-all approaches like antibiotics and steroids that fail to address the root causes of vaginal dysbiosis.
- By combining rigorous research with patented product formulations we are developing personalized solutions to a multitude of chronic and acute vaginal conditions.
- Advanced Microbiome Measurement: We have developed a quantitative PCR (qPCR) testing to provide a translational bridge for HCP's who require precise measurable insights into the vaginal microbiome, going beyond whole genome sequencing to offer actionable data for diagnosis and personalized care.
- Patented BioMatch® Technology: Our groundbreaking BioMatch® technology is clinically proven to optimize vaginal pH and support beneficial Lactobacillus, addressing the root causes of vaginal dysbiosis.
- Groundbreaking Research: The VENUS Study: We're conducting one of the largest observational vaginal microbiome studies in the United States, collecting invaluable data at the moment of diagnosis to advance precision care and inform our product development.
- Robust Intellectual Property:Our patented BioMatch® technology and expanding patent portfolio along with our VENUS Study data are protected, ensuring our continued innovation and leadership in the field.
- VBS is committed to transforming vaginal health, improving clinical outcomes, and empowering women with the knowledge and tools they need to thrive.
- By combining rigorous research with patented product formulations we are developing personalized solutions to a multitude of chronic and acute vaginal conditions. Advanced Microbiome Measurement: We have developed a quantitative PCR (qPCR) testing to provide a translational bridge for HCP’s who require precise measurable insights into the vaginal microbiome, going beyond whole genome sequencing to offer actionable data for diagnosis and personalized care. Patented BioMatch® Technology: Our groundbreaking BioMatch® technology is clinically proven to optimize vaginal pH and support beneficial Lactobacillus, addressing the root causes of vaginal dysbiosis. Groundbreaking Research: The VENUS Study: We’re conducting one of the largest observational vaginal microbiome studies in the United States, collecting invaluable data at the moment of diagnosis to advance precision care and inform our product development. Robust Intellectual Property:Our patented BioMatch® technology and expanding patent portfolio along with our VENUS Study data are protected, ensuring our continued innovation and leadership in the field. VBS is committed to transforming vaginal health, improving clinical outcomes, and empowering women with the knowledge and tools they need to thrive.